机构:[1]Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, PR China.四川大学华西医院[2]Department of Neurosurgery and Institute of Neurosurgery, State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, PR China.四川大学华西医院
[This corrects the article DOI: 10.18632/oncotarget.23507.].
语种:
外文
PubmedID:
第一作者:
第一作者机构:[1]Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, PR China.
推荐引用方式(GB/T 7714):
Hu Yuzhu,Yu Ting,Liu Xiaoxiao,et al.Correction: Improved anti-tumor efficacy via combination of oxaliplatin and fibrin glue in colorectal cancer.[J].Oncotarget.2020,11(37):3484-3485.doi:10.18632/oncotarget.27605.
APA:
Hu Yuzhu,Yu Ting,Liu Xiaoxiao,He Yihong,Deng Lihong...&Gao Xiang.(2020).Correction: Improved anti-tumor efficacy via combination of oxaliplatin and fibrin glue in colorectal cancer..Oncotarget,11,(37)
MLA:
Hu Yuzhu,et al."Correction: Improved anti-tumor efficacy via combination of oxaliplatin and fibrin glue in colorectal cancer.".Oncotarget 11..37(2020):3484-3485